Mortality Excess in Individuals with Elevated IgA Anti-Transglutaminase Antibodies: The KORA/MONICA Augsburg Cohort Study 1989–1998 | Zendy

M.-H. Metzger | Zendy; Margit Heier | Zendy; Markku Mäki | Zendy; E. Bravi | Zendy; Andrea L.C. Schneider | Zendy; Hannelore Löwel | Zendy; Thomas Illig | Zendy; Detlef Schuppan | Zendy; HeinzErich Wichmann | Zendy

Open Access

Mortality Excess in Individuals with Elevated IgA Anti-Transglutaminase Antibodies: The KORA/MONICA Augsburg Cohort Study 1989–1998

Author(s) -

M.-H. Metzger,

Margit Heier,

Markku Mäki,

E. Bravi,

Andrea L.C. Schneider,

Hannelore Löwel,

Thomas Illig,

Detlef Schuppan,

HeinzErich Wichmann

Publication year - 2006

Publication title -

european journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.825

H-Index - 111

eISSN - 1573-7284

pISSN - 0393-2990

DOI - 10.1007/s10654-006-9002-4

Subject(s) - medicine , tissue transglutaminase , hazard ratio , antibody , cohort , standardized mortality ratio , population , cohort study , immunoglobulin a , immunology , autoantibody , gastroenterology , immunoglobulin g , confidence interval , enzyme , environmental health , biochemistry , chemistry

Immunoglobulin A (IgA) autoantibodies to tissue transglutaminase (tTG) are commonly used for screening and diagnosing of celiac disease. We examined the hypothesis that elevated IgA anti-tTG antibodies were associated with higher all-cause mortality risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research